Fluconazole Penetration into Cerebrospinal Fluid in Humans
- 1 April 1988
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 28 (4) , 363-366
- https://doi.org/10.1002/j.1552-4604.1988.tb03159.x
Abstract
One hour after intravenous doses of 50 mg/d fluconazole for 6 days or 100 mg/d for seven days to healthy subjects, the cerebrospinal fluid concentrations of fluconazole were 1.26 mg/L and 2.74 mg/L, respectively. These values were approximately 52% and 62% those of serum. Four patients with an initial clinical diagnosis of meningitis also had significant concentrations of fluconazole in the cerebrospinal fluid.This publication has 20 references indexed in Scilit:
- Treatment of cryptococcal meningitis in mice with fluconazoleJournal of Antimicrobial Chemotherapy, 1986
- Infection in cancer patients: A continuing associationThe American Journal of Medicine, 1986
- Fungal Infections in Patients with AIDS and AIDS-related ComplexScandinavian Journal of Infectious Diseases, 1986
- Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humansAntimicrobial Agents and Chemotherapy, 1985
- Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytesAntimicrobial Agents and Chemotherapy, 1985
- Bone Marrow Toxicity Associated with 5-Fluorocytosine TherapyAntimicrobial Agents and Chemotherapy, 1977
- Development of Resistance to 5-Fluorocytosine in Candida parapsilosis during TherapyThe Journal of Infectious Diseases, 1974
- Variables Influencing Susceptibility Testing of Cryptococcus neoformans to 5-FluorocytosineAntimicrobial Agents and Chemotherapy, 1973
- In Vitro Studies of 5-Fluorocytosine Resistance in Candida albicans and Torulopsis glabrataAntimicrobial Agents and Chemotherapy, 1972
- A Pharmacologic Guide to the Clinical Use of Amphotericin BThe Journal of Infectious Diseases, 1969